1. A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma. Issue 6 (December 2020) Authors: Mattei, Jane; Ballhausen, Alexej; Bassett, Roland; Shephard, Michael; Chattopadhyay, Chandrani; Hudgens, Courtney; Tetzlaff, Michael; Woodman, Scott; Sato, Takami; Patel, Sapna P. Journal: Melanoma research Issue: Volume 30:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study. Issue 6 (20th February 2021) Authors: Pelster, Meredith S.; Gruschkus, Stephen K.; Bassett, Roland; Gombos, Dan S.; Shephard, Michael; Posada, Liberty; Glover, Maura S.; Simien, Rinata; Diab, Adi; Hwu, Patrick; Carter, Brett W.; Patel, Sapna P. Journal: Journal of clinical oncology Issue: Volume 39:Issue 6(2021) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗